60 Degrees shares surge 10.61% intraday after announcing 1:4 reverse stock split to meet Nasdaq compliance.

60 Degrees Pharmaceuticals surged 10.61% intraday following the announcement of a 1:4 reverse stock split effective January 20, 2026, aimed at complying with Nasdaq’s minimum bid price requirement. The split reduces outstanding shares from ~5.15 million to ~1.29 million, with trading resuming under the existing ticker "SXTP." While the move addresses technical listing criteria, it follows a similar 1:5 split in February 2025, signaling persistent price pressure. The immediate intraday rally reflects a mechanical price adjustment post-split, as the stock’s nominal value quadruples, though underlying fundamentals remain unchanged. Market participants remain skeptical about long-term sustainability, as the split does not resolve broader financial or operational challenges.